With 0.54 million shares changed hands, the volume of the stock remained heavier than its average volume of 88090.0 shares. During the session, the Packaged Foods company that operates in wider Consumer Defensive sector, reached to the highest price of $10.58 whereas the lowest price it dropped to was $7.7932. The 52-week range on CLNN shows that it touched its highest point at $8.05 and its lowest point at $2.28 during that stretch. It currently has a 1-year price target of $30.43. Beta for the stock currently stands at 0.61.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CLNN was up-trending over the past week, with a rise of 78.74%, but this was up by 76.64% over a month. Three-month performance surged to 171.58% while six-month performance rose 244.59%. The stock gained 97.93% in the past year, while it has gained 128.48% so far this year. A look at the trailing 12-month EPS for CLNN yields -2.60 with Next year EPS estimates of -1.87. For the next quarter, that number is -0.58. This implies an EPS growth rate of 63.16% for this year and 10.61% for next year.
Float and Shares Shorts:
At present, 9.46 million CLNN shares are outstanding with a float of 6.64 million shares on hand for trading. On 2025-09-15, short shares totaled 0.34 million, which was 340.00000000000006 higher than short shares on 1755216000. In addition to Mr. Robert Etherington MBA as the firm’s CEO, President & Director, Mr. Morgan R. Brown CPA, M.B.A. serves as its Chief Financial Officer.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2025-06-30, CLNN reported revenue of $27000.0 and operating income of -$5628000.0. The EBITDA in the recently reported quarter was -$5420000.0 and diluted EPS was -$0.78.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for CLNN since 4 analysts follow the stock currently. There are 4 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With CLNN analysts setting a high price target of 48.0 and a low target of 20.0, the average target price over the next 12 months is 30.42857. Based on these targets, CLNN could surge 356.71% to reach the target high and rise by 90.29% to reach the target low. Reaching the average price target will result in a growth of 189.52% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$4.34711 being high and -$4.55289 being low. For CLNN, this leads to a yearly average estimate of -$4.45. The surprise factor in the prior quarter was -$0.78. Based on analyst estimates, the high estimate for the next quarter is -$0.24 and the low estimate is -$0.89. The average estimate for the next quarter is thus -$0.59.
